PAT Won't Be Mandated (But Don't Look for Any New Incentives Either): CDER Deputy Director Webber

"Ajaz the Avenger" on the Need for Unity: For PAT and QbD, Pharma Must Learn from Bioprocessing

Big Tobacco and the PAT Brain Drain

Ali Afnan to Leave FDA

Dialogue with FDA: Can You Speak the Language?

Raman and the Quest for a Standard Spectroscopic Library

Excipient Inspection and Standard-Setting: A New Role for a High-Level FDA Alumnus?

Mylan Labs and Pharma's Little Chernobyls

FDA Commissioner Hamburg on Enforcement: "My Own Naivete May Move Things Forward"